Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis

Vidyut Bhatia; Anupam Sibal; Shilpy Rajgarhia

doi:10.1093/tropej/fmt048

Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis

Vidyut Bhatia^*, Anupam Sibal, Shilpy Rajgarhia

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Abstract

Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampicin and pyrazinamide. A 14-year-old male diagnosed with disseminated tuberculosis developed purpuric lesions after 1.5 months of treatment. Histopathology was consistent with leukocytoclastic vasculitis. Skin lesion improved after cessation of the two drugs and treatment with corticosteroids.

Original language	English
Article number	fmt048
Pages (from-to)	507-508
Number of pages	2
Journal	Journal of Tropical Pediatrics
Volume	59
Issue number	6
DOIs	https://doi.org/10.1093/tropej/fmt048
Publication status	Published - Dec 2013
Externally published	Yes

Keywords

Cutaneous leukocytoclastic vasculitis
Pyrazinamide
Rifampicin

Access to Document

10.1093/tropej/fmt048

Link to publication in Scopus

Cite this

@article{1db908e1b2bc4960a6e57c7c97599190,

title = "Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis",

abstract = "Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampicin and pyrazinamide. A 14-year-old male diagnosed with disseminated tuberculosis developed purpuric lesions after 1.5 months of treatment. Histopathology was consistent with leukocytoclastic vasculitis. Skin lesion improved after cessation of the two drugs and treatment with corticosteroids.",

keywords = "Cutaneous leukocytoclastic vasculitis, Pyrazinamide, Rifampicin",

author = "Vidyut Bhatia and Anupam Sibal and Shilpy Rajgarhia",

year = "2013",

month = dec,

doi = "10.1093/tropej/fmt048",

language = "English",

volume = "59",

pages = "507--508",

journal = "Journal of Tropical Pediatrics",

issn = "0142-6338",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis

AU - Bhatia, Vidyut

AU - Sibal, Anupam

AU - Rajgarhia, Shilpy

PY - 2013/12

Y1 - 2013/12

N2 - Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampicin and pyrazinamide. A 14-year-old male diagnosed with disseminated tuberculosis developed purpuric lesions after 1.5 months of treatment. Histopathology was consistent with leukocytoclastic vasculitis. Skin lesion improved after cessation of the two drugs and treatment with corticosteroids.

AB - Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampicin and pyrazinamide. A 14-year-old male diagnosed with disseminated tuberculosis developed purpuric lesions after 1.5 months of treatment. Histopathology was consistent with leukocytoclastic vasculitis. Skin lesion improved after cessation of the two drugs and treatment with corticosteroids.

KW - Cutaneous leukocytoclastic vasculitis

KW - Pyrazinamide

KW - Rifampicin

UR - http://www.scopus.com/inward/record.url?scp=84888990570&partnerID=8YFLogxK

U2 - 10.1093/tropej/fmt048

DO - 10.1093/tropej/fmt048

M3 - Article

C2 - 23780994

AN - SCOPUS:84888990570

VL - 59

SP - 507

EP - 508

JO - Journal of Tropical Pediatrics

JF - Journal of Tropical Pediatrics

SN - 0142-6338

IS - 6

M1 - fmt048

ER -

Antituberculosis therapy-associated cutaneous leukocytoclastic vasculitis

Abstract

Keywords

Access to Document

Fingerprint

Cite this